| | % | % 5 Tage | % 1. Jan. | Veränd. 1 J. | Veränd. 3 J. | Wert (M$) |
 | INTRA-CELLULAR THERAPIES, INC. | -2.09% | -0.42% | -9.77% | 4.39% | 100.55% | 4 522 |
| | | | | | | |
| VERTEX PHARMACEUTICALS | 0.13% | 4.25% | 11.31% | 32.27% | 38.57% | 82 513 |
| REGENERON PHARMACEUTICALS, INC. | 0.07% | 3.74% | 2.96% | 18.87% | 115.89% | 79 336 |
| BIONTECH SE | 0.79% | 0.61% | -4.37% | -11.44% | 319.81% | 34 912 |
| BEIGENE, LTD. | -0.70% | -2.48% | 18.12% | 22.01% | 63.17% | 27 008 |
 | GENMAB A/S | 0.15% | -3.07% | -9.69% | 23.82% | 74.91% | 25 338 |
 | ARGENX SE | -1.20% | -2.50% | -0.49% | 52.82% | 163.77% | 20 815 |
| SAREPTA THERAPEUTICS, INC. | -1.27% | -5.63% | -5.16% | 76.34% | 4.21% | 10 788 |
| NEUROCRINE BIOSCIENCES, INC. | -0.12% | -2.79% | -9.37% | 41.08% | 6.56% | 10 407 |
| LEGEND BIOTECH CORPORATION | -2.10% | -2.80% | 5.59% | 40.71% | --.--% | 8 824 |
| ASCENDIS PHARMA A/S | 0.80% | -0.42% | 0.30% | 2.29% | -9.91% | 6 860 |
| HALOZYME THERAPEUTICS, INC. | -4.82% | -1.46% | -10.88% | 55.74% | 161.12% | 6 857 |
| KARUNA THERAPEUTICS, INC. | 0.41% | 2.56% | 0.19% | 82.57% | 94.95% | 6 765 |
 | REMEGEN CO., LTD. | 1.03% | 4.31% | 19.00% | 43.24% | --.--% | 6 004 |
| EXELIXIS, INC. | -1.36% | 4.42% | 8.92% | -1.69% | -2.29% | 5 635 |
| AKESO, INC. | 0.99% | 6.69% | 18.60% | 151.85% | --.--% | 5 479 |
| | | | | | | |
| | Durchschnitt | -0.48% | 0.36% | 3.00% | 42.03% | 85.90% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.15% | 1.33% | 3.97% | 28.76% | 101.93% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
